Table 3.
Genetic Model | First Author, Publication Year | NSCL/P | Control | Weight | Odds Ratio | ||
---|---|---|---|---|---|---|---|
Events | Total | Events | Total | M-H, Random, 95%CI | |||
G vs. A | Pan, 2011 | 277 | 742 | 274 | 768 | 9.2% | 1.07 [0.87, 1.32] |
Mostowska, 2012 | 183 | 412 | 422 | 892 | 8.7% | 0.89 [0.70, 1.13] | |
Huang, 2012 | 204 | 600 | 223 | 708 | 8.8% | 1.12 [0.89, 1.41] | |
Fontoura, 2012 | 290 | 640 | 449 | 800 | 9.2% | 0.65 [0.53, 0.80] | |
Zhong-wei, 2013 | 163 | 362 | 86 | 208 | 6.7% | 1.16 [0.82, 1.64] | |
Bagordakis, 2013 | 310 | 598 | 342 | 767 | 9.1% | 1.34 [1.08, 1.66] | |
Ludwig, 2014 | 139 | 286 | 295 | 658 | 7.9% | 1.16 [0.88, 1.54] | |
Mi, 2015 | 164 | 444 | 195 | 648 | 8.3% | 1.36 [1.05, 1.76] | |
do Rego Borges, 2015 | 282 | 586 | 369 | 704 | 9.0% | 0.84 [0.68, 1.05] | |
Babu Gurramkonda, 2015 | 124 | 288 | 150 | 352 | 7.2% | 1.02 [0.74, 1.39] | |
Velázquez-Aragón, 2016 | 120 | 264 | 273 | 518 | 7.5% | 0.75 [0.56, 1.01] | |
Wu, 2018 | 174 | 496 | 193 | 560 | 8.3% | 1.03 [0.80, 1.32] | |
Subtotal (95%CI) | 5718 | 7583 | 100.0% | 1.01 [0.88, 1.15] | |||
Total Events | 2430 | 3271 | |||||
Heterogeneity: Tau2 = 0.04; Chi2 = 39.48, df = 11 (p < 0.0001); I2 = 72%; Test for overall effect: Z = 0.10 (p = 0.92) | |||||||
GG vs. AA | Pan, 2011 | 51 | 226 | 57 | 224 | 9.1% | 0.85 [0.55, 1.32] |
Mostowska, 2012 | 39 | 101 | 96 | 216 | 8.8% | 0.79 [0.49, 1.27] | |
Huang, 2012 | 39 | 174 | 26 | 183 | 8.3% | 1.74 [1.01, 3.01] | |
Fontoura, 2012 | 86 | 202 | 123 | 197 | 9.4% | 0.45 [0.30, 0.67] | |
Zhong-wei, 2013 | 36 | 60 | 18 | 54 | 6.6% | 3.00 [1.39, 6.45] | |
Bagordakis, 2013 | 85 | 159 | 85 | 212 | 9.3% | 1.72 [1.13, 2.60] | |
Ludwig, 2014 | 33 | 70 | 66 | 166 | 8.1% | 1.35 [0.77, 2.37] | |
Mi, 2015 | 30 | 118 | 29 | 187 | 8.1% | 1.86 [1.05, 3.29] | |
do Rego Borges, 2015 | 65 | 141 | 91 | 165 | 9.0% | 0.70 [0.44, 1.09] | |
Babu Gurramkonda, 2015 | 26 | 72 | 35 | 96 | 7.6% | 0.99 [0.52, 1.86] | |
Velázquez-Aragón, 2016 | 32 | 76 | 68 | 122 | 8.0% | 0.58 [0.32, 1.03] | |
Wu, 2018 | 29 | 132 | 24 | 135 | 7.8% | 1.30 [0.71, 2.38] | |
Subtotal (95%CI) | 1531 | 1957 | 100.0% | 1.08 [0.79, 1.47] | |||
Total EVENTS | 551 | 718 | |||||
Heterogeneity: Tau2 = 0.23; Chi2 = 47.66, df = 11 (p < 0.00001); I2 = 77%; Test for overall effect: Z = 0.47 (p = 0.64) | |||||||
AG vs. AA | Pan, 2011 | 175 | 320 | 160 | 327 | 9.3% | 1.26 [0.92, 1.72] |
Mostowska, 2012 | 105 | 167 | 230 | 350 | 8.6% | 0.88 [0.60, 1.30] | |
Huang, 2012 | 126 | 261 | 171 | 328 | 9.2% | 0.86 [0.62, 1.19] | |
Fontoura, 2012 | 118 | 234 | 203 | 277 | 8.7% | 0.37 [0.26, 0.54] | |
Zhong-wei, 2013 | 91 | 145 | 50 | 86 | 6.9% | 1.21 [0.70, 2.09] | |
Bagordakis, 2013 | 140 | 214 | 172 | 299 | 8.8% | 1.40 [0.97, 2.01] | |
Ludwig, 2014 | 73 | 110 | 163 | 263 | 7.7% | 1.21 [0.76, 1.93] | |
Mi, 2015 | 104 | 192 | 137 | 295 | 8.8% | 1.36 [0.95, 1.96] | |
Babu Gurramkonda, 2015 | 72 | 118 | 80 | 141 | 7.4% | 1.19 [0.73, 1.96] | |
do Rego Borges, 2015 | 152 | 228 | 187 | 261 | 8.6% | 0.79 [0.54, 1.16] | |
Velázquez-Aragón, 2016 | 56 | 100 | 137 | 191 | 7.3% | 0.50 [0.30, 0.83] | |
Wu, 2018 | 116 | 219 | 145 | 256 | 8.8% | 0.86 [0.60, 1.24] | |
Subtotal (95% CI) | 2308 | 3074 | 100.0% | 0.93 [0.73, 1.17] | |||
Total Events | 1328 | 1835 | |||||
Heterogeneity: Tau2 = 0.13; Chi2 = 46.53, df = 11 (p < 0.00001); I2 = 76%; Test for overall effect: Z = 0.63 (p = 0.53) | |||||||
AG + GG vs. AA | Pan, 2011 | 226 | 371 | 217 | 384 | 9.1% | 1.20 [0.90, 1.60] |
Fontoura, 2012 | 204 | 320 | 326 | 400 | 8.7% | 0.40 [0.28, 0.56] | |
Huang, 2012 | 165 | 300 | 197 | 354 | 8.9% | 0.97 [0.71, 1.33] | |
Mostowska, 2012 | 144 | 206 | 326 | 446 | 8.5% | 0.85 [0.59, 1.23] | |
Zhong-wei, 2013 | 127 | 181 | 68 | 104 | 7.2% | 1.25 [0.74, 2.08] | |
Bagordakis, 2013 | 225 | 299 | 257 | 384 | 8.7% | 1.50 [1.07, 2.11] | |
Ludwig, 2014 | 106 | 143 | 229 | 329 | 7.8% | 1.25 [0.80, 1.95] | |
Mi, 2015 | 134 | 222 | 166 | 324 | 8.6% | 1.45 [1.03, 2.05] | |
do Rego Borges, 2015 | 217 | 293 | 278 | 352 | 8.5% | 0.76 [0.53, 1.10] | |
Babu Gurramkonda, 2015 | 68 | 144 | 115 | 176 | 7.7% | 0.47 [0.30, 0.75] | |
Velázquez-Aragón, 2016 | 88 | 132 | 205 | 259 | 7.6% | 0.53 [0.33, 0.84] | |
Wu, 2018 | 145 | 248 | 169 | 280 | 8.6% | 0.92 [0.65, 1.31] | |
Subtotal (95%CI) | 2859 | 3792 | 100.0% | 0.89 [0.70, 1.14] | |||
Total Events | 1849 | 2553 | |||||
Heterogeneity: Tau2 = 0.15; Chi2 = 59.28, df = 11 (p < 0.00001); I2 = 81%; Test for overall effect: Z = 0.90 (p = 0.37) | |||||||
GG vs. AA + AG | Pan, 2011 | 51 | 371 | 57 | 384 | 9.6% | 0.91 [0.61, 1.37] |
Fontoura, 2012 | 86 | 320 | 123 | 400 | 12.2% | 0.83 [0.60, 1.15] | |
Huang, 2012 | 39 | 300 | 26 | 354 | 6.9% | 1.89 [1.12, 3.18] | |
Mostowska, 2012 | 39 | 206 | 96 | 446 | 9.4% | 0.85 [0.56, 1.29] | |
Bagordakis, 2013 | 85 | 299 | 85 | 384 | 11.4% | 1.40 [0.99, 1.98] | |
Zhong-wei, 2013 | 36 | 181 | 18 | 104 | 5.3% | 1.19 [0.63, 2.22] | |
Ludwig, 2014 | 33 | 143 | 66 | 329 | 7.9% | 1.20 [0.74, 1.92] | |
do Rego Borges, 2015 | 65 | 293 | 91 | 352 | 10.9% | 0.82 [0.57, 1.18] | |
Mi, 2015 | 30 | 222 | 29 | 324 | 6.6% | 1.59 [0.92, 2.73] | |
Babu Gurramkonda, 2015 | 26 | 144 | 35 | 176 | 6.2% | 0.89 [0.51, 1.56] | |
Velázquez-Aragón, 2016 | 32 | 132 | 68 | 259 | 7.7% | 0.90 [0.55, 1.46] | |
Wu, 2018 | 29 | 248 | 24 | 280 | 6.1% | 1.41 [0.80, 2.50] | |
Subtotal (95%CI) | 2859 | 3792 | 100.0% | 1.08 [0.91, 1.26] | |||
Total Events | 551 | 718 | |||||
Heterogeneity: Tau2 = 0.03; Chi2 = 17.14, df = 11 (p = 0.10); I2 = 36%; Test for overall effect: Z = 0.87 (p = 0.38) |
Abbreviations: NSCL/P, non-syndromic cleft lip with or without a cleft palate; CI, confidence interval. All models were analyzed based on random-effects model except for “GG vs. AA + AG” that was based on fixed-effects model